NCT03118895View on ClinicalTrials.gov

Leaders Free III: BioFreedom™ Clinical Trial

NACompletedINTERVENTIONAL
Enrollment

404

Participants

Timeline

Start Date

November 8, 2017

Primary Completion Date

September 5, 2019

Study Completion Date

November 18, 2022

Conditions
Cardiac DeathMyocardial InfarctionStent ThrombosisBleedingMortality
Interventions
DEVICE

BioFreedom™ BA9™ drug-coated stent

Drug-coated stent for coronary arteries

Trial Locations (2)

91480

at Hôpital Privé Claude Galien ICPS, Quincy-sous-Sénart

Unknown

Triemli Stadtspital, Zurich

All Listed Sponsors
collaborator

European Cardiovascular Research Center

NETWORK

lead

Biosensors Europe SA

INDUSTRY

NCT03118895 - Leaders Free III: BioFreedom™ Clinical Trial | Biotech Hunter | Biotech Hunter